Abstract
A simple HPLC assay to determine plasma concentration of tipranavir is presented. A liquid/liquid extraction of the drugs in ethyl acetate/hexane from 250 microL of plasma is followed by a reversed phase isocratic HPLC assay with UV detection at 205 nm. The imprecision and inaccuracy are lower than 10%, the low limit of quantitation is 0.4 mg/L. Thus, this method can be used for therapeutic drug monitoring of tipranavir in HIV infected patients.
MeSH terms
-
Chromatography, High Pressure Liquid / methods*
-
HIV Infections / blood
-
HIV Infections / drug therapy*
-
Humans
-
Pyridines / blood*
-
Pyridines / therapeutic use
-
Pyrones / blood*
-
Pyrones / therapeutic use
-
Reproducibility of Results
-
Reverse Transcriptase Inhibitors / blood*
-
Reverse Transcriptase Inhibitors / therapeutic use
-
Sensitivity and Specificity
-
Spectrophotometry, Ultraviolet
-
Sulfonamides
Substances
-
Pyridines
-
Pyrones
-
Reverse Transcriptase Inhibitors
-
Sulfonamides
-
tipranavir